Skip to main content
Journal cover image

Biomarkers for amyotrophic lateral sclerosis.

Publication ,  Journal Article
Bowser, R; Cudkowicz, M; Kaddurah-Daouk, R
Published in: Expert Rev Mol Diagn
May 2006

Amyotrophic lateral sclerosis (ALS) is the most common form of motor neuron disease. ALS is a fatal neurodegenerative disease and clinical diagnosis typically takes many months to complete. Early disease diagnosis through the use of biomarkers may aid in correct clinical management of patients and possibly delay time to ventilator and morbidity. This review explores the progress of biomarker discovery efforts for ALS and the many challenges that remain. Included are different technologies utilized in biomarker discovery efforts (proteomic, genomic and metabolomic) and putative biomarkers uncovered using these techniques. These studies have discovered genetic mutations leading to familial forms of ALS, and specific protein alterations that occur in biological fluids (cerebrospinal fluid and blood) and/or tissues of ALS subjects. More recent high-throughput technologies have revealed panels of proteomic or metabolic biomarkers that can discriminate between ALS and control groups. The identification of disease-specific biomarkers will provide opportunities to develop early diagnostic measures as well as surrogate markers to monitor disease progression and test drug efficacy in clinical trials.

Duke Scholars

Published In

Expert Rev Mol Diagn

DOI

EISSN

1744-8352

Publication Date

May 2006

Volume

6

Issue

3

Start / End Page

387 / 398

Location

England

Related Subject Headings

  • Proteomics
  • Mutation
  • Muscles
  • Motor Neurons
  • Molecular Diagnostic Techniques
  • Humans
  • Genomics
  • Gene Expression Profiling
  • Biomarkers
  • Amyotrophic Lateral Sclerosis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Bowser, R., Cudkowicz, M., & Kaddurah-Daouk, R. (2006). Biomarkers for amyotrophic lateral sclerosis. Expert Rev Mol Diagn, 6(3), 387–398. https://doi.org/10.1586/14737159.6.3.387
Bowser, Robert, Merit Cudkowicz, and Rima Kaddurah-Daouk. “Biomarkers for amyotrophic lateral sclerosis.Expert Rev Mol Diagn 6, no. 3 (May 2006): 387–98. https://doi.org/10.1586/14737159.6.3.387.
Bowser R, Cudkowicz M, Kaddurah-Daouk R. Biomarkers for amyotrophic lateral sclerosis. Expert Rev Mol Diagn. 2006 May;6(3):387–98.
Bowser, Robert, et al. “Biomarkers for amyotrophic lateral sclerosis.Expert Rev Mol Diagn, vol. 6, no. 3, May 2006, pp. 387–98. Pubmed, doi:10.1586/14737159.6.3.387.
Bowser R, Cudkowicz M, Kaddurah-Daouk R. Biomarkers for amyotrophic lateral sclerosis. Expert Rev Mol Diagn. 2006 May;6(3):387–398.
Journal cover image

Published In

Expert Rev Mol Diagn

DOI

EISSN

1744-8352

Publication Date

May 2006

Volume

6

Issue

3

Start / End Page

387 / 398

Location

England

Related Subject Headings

  • Proteomics
  • Mutation
  • Muscles
  • Motor Neurons
  • Molecular Diagnostic Techniques
  • Humans
  • Genomics
  • Gene Expression Profiling
  • Biomarkers
  • Amyotrophic Lateral Sclerosis